November 19, 2026 · Annals of surgical oncology · DOI: 10.1245/s10434-026-20886-9

Pathological Response Following Neoadjuvant Chemotherapy in Locally Advanced Gallbladder Cancer: Prognostic Implications and the Role of Mandard Tumor Regression Grading.

Listen to this summary

This retrospective cohort of 86 patients with locally advanced gallbladder cancer who underwent curative resection after neoadjuvant chemotherapy asked whether pathological response predicts survival and what factors drive it. Pathological complete response occurred in 13.25% of evaluable patients, and responders (Mandard grades 1-2) had better overall survival (median not reached vs. 32 months) and disease-free survival (31 vs. 9.2 months) than poor responders (Mandard 3-5), though the DFS difference was not statistically significant (p = 0.057). Neither the chemotherapy regimen nor the number of cycles was associated with pathological response.

Kaival Gundavda, Shraddha Patkar, Sadhana Kannan, Mukta Gobade, Kedar Deodhar, Gauri Deshpande, Rajiv Kaushal, Munita Bal, Mukta Ramadwar, Akshay Baheti, Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, Mahesh Goel, Subhash Yadav

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play